HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Rose Sheet

Executive Summary

Lauder's Dan Brestle retires: The Estee Lauder Companies CEO William Lauder announces that Dan Brestle will retire after 30 years with the company. Brestle, currently vice chairman and president, ELC North America, will retire on June 30, 2009. "It is hard to believe that when Dan joined our company we had just three brands, less than $400 mil. in sales, and only one primary channel of distribution. With the help of Dan's unwavering dedication and leadership, our company has grown to be one of the industry leaders," CEO Lauder says in a March 13 letter to colleagues. Brestle joined the company in 1978 as a member of its operations group. He led the Prescriptives group during its spell of double-digit growth in the 1980s; in the 90s, as president of Clinique Laboratories, Brestle headed the team that launched Clinique Happy, Turnaround Cream, and other signature products. Members of Lauder management to assume Brestle's responsibilities will be announced in the coming weeks

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel